Fine-tuning serotonin2c receptor function in the brain: Molecular and functional implications

被引:75
作者
Berg, Kelly A. [2 ]
Clarke, William R. [2 ]
Cunningham, Kathryn A. [3 ,4 ]
Spampinato, Umberto [1 ]
机构
[1] Univ Victor Segalen Bordeaux 2, Inst Francois Magendie, Ctr Rech, INSERM,U862, F-33076 Bordeaux, France
[2] Univ Texas Hlth Sci Ctr San Antonio, Dept Pharmacol, San Antonio, TX 78229 USA
[3] Univ Texas Med Branch, Addict Res Ctr, Galveston, TX 77555 USA
[4] Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA
基金
美国国家卫生研究院;
关键词
5-HT2c receptor; Constitutive activity; RNA editing; Dopamine; Microdialysis;
D O I
10.1016/j.neuropharm.2008.06.014
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The serotonin(2C) receptor (5-HT2CR) is a member of the serotonin(2) family of 7-transmembrane-spanning (7-TMS) receptors, which possesses unique molecular and pharmacological properties such as constitutive activity and RNA editing. The 5-HT2CR is widely expressed within the central nervous system, where is thought to play a major role in the regulation of neuronal network excitability. In keeping with its ability to modulate dopamine (DA) neuron function in the brain, the 5-HT2CR is currently considered as a major target for improved treatments of neuropsychiatric disorders related to DA neuron dysfunction, such as depression, schizophrenia, Parkinson's disease or drug addiction. The aim of this review is to provide an update of the functional status of the central 5-HT2CR, covering molecular, cellular, anatomical, biochemical and behavioral aspects to highlight its distinctive regulatory properties, the emerging functional significance of constitutive activity and RNA editing in vivo, and the therapeutic potential of inverse agonism. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:969 / 976
页数:8
相关论文
共 131 条
[1]   Agonist-induced GTPγ35S binding mediated by human 5-HT2C receptors expressed in human embryonic kidney 293 cells [J].
Alberts, GL ;
Pregenzer, JF ;
Im, WB ;
Zaworski, PG ;
Gill, GS .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 383 (03) :311-319
[2]  
Alewijnse AE, 2000, MOL PHARMACOL, V57, P890
[3]   Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission [J].
Alex, K. D. ;
Pehek, E. A. .
PHARMACOLOGY & THERAPEUTICS, 2007, 113 (02) :296-320
[4]   Modulation of dopamine release by striatal 5-HT2C receptors [J].
Alex, KD ;
Yavanian, GJ ;
McFarlane, HG ;
Pluto, CP ;
Pehek, EA .
SYNAPSE, 2005, 55 (04) :242-251
[5]   Deletion of the serotonin 5-HT2C receptor PDZ recognition motif prevents receptor phosphorylation and delays resensitization of receptor responses [J].
Backstrom, JR ;
Price, RD ;
Reasoner, DT ;
Sanders-Bush, E .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (31) :23620-23626
[6]   Agonist-directed signaling of serotonin 5-HT2C receptors:: Differences between serotonin and lysergic acid diethylamide (LSD) [J].
Backstrom, JR ;
Chang, MS ;
Chu, H ;
Niswender, CM ;
Sanders-Bush, E .
NEUROPSYCHOPHARMACOLOGY, 1999, 21 (02) :S77-S81
[7]   Serotonin-induced increases in adult cell proliferation and neurogenesis are mediated through different and common 5-HT receptor subtypes in the dentate gyrus and the subventricular zone [J].
Banasr, M ;
Hery, M ;
Printemps, R ;
Daszuta, A .
NEUROPSYCHOPHARMACOLOGY, 2004, 29 (03) :450-460
[8]   Serotonin-GABA interactions modulate MDMA-induced mesolimbic dopamine release [J].
Bankson, MG ;
Yamamoto, BK .
JOURNAL OF NEUROCHEMISTRY, 2004, 91 (04) :852-859
[9]   A review of central 5-HT receptors and their function [J].
Barnes, NM ;
Sharp, T .
NEUROPHARMACOLOGY, 1999, 38 (08) :1083-1152
[10]   The serotonin 5-HT2A and 5-HT2C receptors interact with specific sets of PDZ proteins [J].
Bécamel, C ;
Gavarini, S ;
Chanrion, B ;
Alonso, G ;
Galéotti, N ;
Dumuis, A ;
Bockaert, J ;
Marin, P .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (19) :20257-20266